Page last updated: 2024-08-24

rhodamine 123 and Diffuse Mixed Small and Large Cell Lymphoma

rhodamine 123 has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Capel, P; Delville, JP; Feremans, W; Kiss, R; Pauwels, O; Pradier, O; Van Onderbergen, A1
Lizard, G; Lizard-Nacol, S; Maynadié, M; Poupon, MF; Roignot, P1
Amiot, L; Drénou, B; Fauchet, R; Lamy, T; Le Prisé, PY1

Other Studies

3 other study(ies) available for rhodamine 123 and Diffuse Mixed Small and Large Cell Lymphoma

ArticleYear
Comparative study of multidrug resistance evaluated by means of the quantitative immunohistochemical detection of P-glycoprotein and the functional release of rhodamine 123.
    American journal of hematology, 1995, Volume: 49, Issue:3

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Drug Resistance, Multiple; Flow Cytometry; Humans; Immunoenzyme Techniques; Immunohistochemistry; Kinetics; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Mice; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rhodamine 123; Rhodamines; Tumor Cells, Cultured

1995
Evaluation of multidrug resistant phenotype by flow cytometry with monoclonal antibodies and functional tests.
    Bulletin du cancer, 1995, Volume: 82, Issue:3

    Topics: Antibodies, Monoclonal; Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Daunorubicin; Drug Resistance, Multiple; Flow Cytometry; Fluorescent Antibody Technique; Fluorescent Dyes; Humans; Leukemia, Erythroblastic, Acute; Lymphoma, Non-Hodgkin; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rhodamine 123; Rhodamines

1995
Multidrug resistance in aggressive lymphoproliferative disorders of T and natural-killer origin.
    Leukemia & lymphoma, 1998, Volume: 30, Issue:3-4

    Topics: Antigens, CD; Drug Resistance, Multiple; Fluorescent Dyes; Humans; Immunophenotyping; Killer Cells, Natural; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Rhodamine 123; Rhodamines; T-Lymphocytes

1998